Mark McPartland
Senior Vice President, Investor Relations
Head of Investor Relations
Analyst — Host
Earnings-call appearances
-
Vistagen Therapeutics, Inc. Q3 FY2025 Earnings Call2025-02-13
Vistagen Therapeutics, Inc. (VTGN)
-
Vistagen Therapeutics, Inc. Q2 FY2025 Earnings Call2024-11-07
Vistagen Therapeutics, Inc. (VTGN)
-
Vistagen Therapeutics, Inc. Q4 FY2024 Earnings Call2024-06-11
Vistagen Therapeutics, Inc. (VTGN)
-
Vistagen Therapeutics, Inc. Q3 FY2024 Earnings Call2024-02-13
Vistagen Therapeutics, Inc. (VTGN)
-
Vistagen Therapeutics, Inc. Q2 FY2024 Earnings Call2023-11-09
Vistagen Therapeutics, Inc. (VTGN)